|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanda M, Tateishi R, Yoshida H, Sato T,
Masuzaki R, Ohki T, Imamura J, Goto T, Yoshida H, Hamamura K, et
al: Extrahepatic metastasis of hepatocellular carcinoma: Incidence
and risk factors. Liver Int. 28:1256–1263. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gluer AM, Cocco N, Laurence JM, Johnston
ES, Hollands MJ, Pleass HC, Richardson AJ and Lam VW: Systematic
review of actual 10-year survival following resection for
hepatocellular carcinoma. HPB (Oxford). 14:285–290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanaka K, Shimada H, Matsuo K, Takeda K,
Nagano Y and Togo S: Clinical features of hepatocellular carcinoma
developing extrahepatic recurrences after curative resection. World
J Surg. 32:1738–1747. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Y, Nagano H, Ota H, Morimoto O,
Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A,
et al: Patterns and clinicopathologic features of extrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Surgery. 141:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuen MF, Ahn SH, Chen DS, Chen PJ,
Dusheiko GM, Hou JL, Maddrey WC, Mizokami M, Seto WK, Zoulim F and
Lai CL: Chronic hepatitis B virus infection: Disease revisit and
management recommendations. J Clin Gastroenterol. 50:286–294. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzumura K, Hirano T, Kuroda N, Iimuro Y,
Okada T, Hashimoto M, Hasegawa S and Fujimoto J: Solitary
mediastinal metastasis of hepatocellular carcinoma treated by
video-assisted thoracic surgery: Report of a case. Gen Thorac
Cardiovasc Surg. 61:651–654. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hung JJ, Lin SC and Hsu WH: Pancoast
syndrome caused by metastasis to the superior mediastinum of
hepatocellular carcinoma. Thorac Cardiovasc Surg. 55:463–465. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CC, Yeh HZ, Chang CS, Ko CW, Lien HC,
Wu CY and Hung SW: Transarterial embolization of metastatic
mediastinal hepatocellular carcinoma. World J Gastroenterol.
19:3512–3516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oh SY, Seo KW, Jegal Y, Ahn JJ, Min YJ,
Park CR and Hwang JC: Hemothorax caused by spontaneous rupture of a
metastatic mediastinal lymph node in hepatocellular carcinoma: A
case report. Korean J Intern Med. 28:622–625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiaohong S, Huikai L, Feng W, Ti Z,
Yunlong C and Qiang L: Clinical significance of lymph node
metastasis in patients undergoing partial hepatectomy for
hepatocellular carcinoma. World J Surg. 34:1028–1033. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amini N, Ejaz A, Spolverato G, Maithel SK,
Kim Y and Pawlik TM: Management of lymph nodes during resection of
hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A
systematic review. J Gastrointest Surg. 18:2136–2148. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ueda J, Yoshida H, Mamada Y, Taniai N,
Mineta S, Yoshioka M, Kawano Y, Shimizu T, Hara E, Kawamoto C, et
al: Surgical resection of a solitary para-aortic lymph node
metastasis from hepatocellular carcinoma. World J Gastroenterol.
18:3027–3031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao F, Gu Y, Huang J, Zhao M and Wu P:
Radiofrequency ablation of retroperitoneal metastatic lymph nodes
from hepatocellular carcinoma. Acad Radiol. 19:1035–1040. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jang WI, Kim MS, Bae SH, Cho CK, Yoo HJ,
Seo YS, Kang JK, Kim SY, Lee DH, Han CJ, et al: High-dose
stereotactic body radiotherapy correlates increased local control
and overall survival in patients with inoperable hepatocellular
carcinoma. Radiat Oncol. 8:2502013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS,
Jang JW, Choi JY, Yoon SK and Chung KW: Long-term effect of
stereotactic body radiation therapy for primary hepatocellular
carcinoma ineligible for local ablation therapy or surgical
resection. Stereotactic radiotherapy for liver cancer. BMC Cancer.
10:4752010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang WY, Jen YM, Lee MS, Chang LP, Chen
CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, et al: Stereotactic
body radiation therapy in recurrent hepatocellular carcinoma. Int J
Radiat Oncol Biol Phys. 84:355–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim K, Chie EK, Kim W, Kim YJ, Yoon JH,
Lee HS and Ha SW: Absence of symptom and intact liver function are
positive prognosticators for patients undergoing radiotherapy for
lymph node metastasis from hepatocellular carcinoma. Int J Radiat
Oncol Biol Phys. 78:729–734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon SM, Kim JH, Choi EK, Ahn SD, Lee SW,
Yi BY, Chung YW, Lee YS and Seo DJ: Radioresponse of hepatocellular
carcinoma-treatment of lymph node metastasis. Cancer Res Treat.
36:79–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bruix J, Raoul JL, Sherman M, Mazzaferro
V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M,
Sangiovanni A, et al: Efficacy and safety of sorafenib in patients
with advanced hepatocellular carcinoma: Subanalyses of a phase III
trial. J Hepatol. 57:821–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raoul JL, Bruix J, Greten TF, Sherman M,
Mazzaferro V, Hilgard P, Scherubl H, Scheulen ME, Germanidis G,
Dominguez S, et al: Relationship between baseline hepatic status
and outcome, and effect of sorafenib on liver function: SHARP trial
subanalyses. J Hepatol. 56:1080–1088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abou-Alfa GK, Amadori D, Santoro A, Figer
A, De Greve J, Lathia C, Voliotis D, Anderson S, Moscovici M and
Ricci S: Safety and efficacy of sorafenib in patients with
hepatocellular carcinoma (HCC) and Child-Pugh A versus B cirrhosis.
Gastrointest Cancer Res. 4:40–44. 2011.PubMed/NCBI
|
